Background A conceptual framework has been developed specifically for cost-related
nonadherence (CRNA) that differs from models proposed for general medication …

Abstract The United States pays more for medical care than any other nation in the world,
including for prescription drugs. These costs are inequitably distributed, as individuals from …

Prescription drug cost-sharing is a barrier to medication adherence, particularly for low-
income and minority populations. In this systematic review, we examined the impact of …

Objectives Policy efforts to reduce the cost of prescription medications in the US have failed
to reduce disparities in cost-related underuse. Little is known about the relationships …

Background Most older adults use medications that may increase falls, often defined as fall
risk increasing drugs or “FRIDs”. Two definitions for FRIDs, the Centers for Disease Control …

Objectives Medication access and adherence play key roles in determining patient
outcomes. We investigated whether cost-related non-adherence (CRNA) to prescription …

Wealth resources have been mostly omitted from the study of how socioeconomic status
shapes health outcomes. In the United States (USA), there is a growing body of evidence …

Objectives To examine ethnoracial disparities in antidementia medication use, accounting
for implementation of Part D, and to evaluate the role of prescription drug coverage as a …

Using nationally representative data from the Health and Retirement Study, this study
examined (1) whether awareness of the Medicare Part D Low-Income Subsidy (LIS) varies …

Objective Many effective medical therapies are available for treating neurological diseases,
but these therapies tend to be expensive and adherence is critical to their effectiveness. We …